Davis Randall S, Ehrhardt Goetz R A, Leu Chuen-Miin, Hirano Masayuki, Cooper Max D
Division of Developmental and Clinical Immunology, University of Alabama, Birmingham, USA.
Eur J Immunol. 2005 Mar;35(3):674-80. doi: 10.1002/eji.200425886.
A surprising number of Fc receptor (FcR) relatives have been recognized recently with the potential capacity to modulate innate and adaptive immune responses. The six human FcR homologs (FcRH1-6), which belong to a phylogenetically conserved gene family, have variable numbers of extracellular immunoglobulin domains of five different subtypes. FcRH immunoregulatory potential is implicated by the presence of consensus tyrosine-based activation or inhibition motifs in their cytoplasmic tails. All but one of these new receptors, FcRH6, are expressed on B cells at different stages in differentiation. Their ligands, function, and prospective roles as diagnostic B cell markers and therapeutic targets are topics of intense interest.
最近,人们认识到数量惊人的Fc受体(FcR)亲属具有调节先天性和适应性免疫反应的潜在能力。六种人类FcR同源物(FcRH1-6)属于一个系统发育保守的基因家族,具有数量可变的五种不同亚型的细胞外免疫球蛋白结构域。FcRH的免疫调节潜力因其细胞质尾部存在基于酪氨酸的共有激活或抑制基序而得到暗示。除了其中一种新受体FcRH6外,所有这些新受体在B细胞分化的不同阶段均有表达。它们的配体、功能以及作为诊断性B细胞标志物和治疗靶点的潜在作用是人们极为感兴趣的话题。